Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.
暂无分享,去创建一个
A. Look | D. Haber | D. Bell | D. Scadden | O. Bernard | R. Okimoto | Sara M. Haserlat | A. McClatchey | D. Sweetser | Daniel A Haber | A Thomas Look | David T Scadden | Farshid Dayyani | Daphne W Bell | David A Sweetser | L. Purton | Olivier A Bernard | Ross A Okimoto | Sara M Haserlat | Louise E Purton | Woo Jae Kim | Meagan Goodwin | Andrea I McClatchey | F. Dayyani | Meagan Goodwin | W. J. Kim | Farshid Dayyani
[1] A. Feinberg,et al. An X Chromosome Gene, WTX, Is Commonly Inactivated in Wilms Tumor , 2007, Science.
[2] M. Wigler,et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.
[3] Y. Hannun,et al. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. , 1991, The Journal of biological chemistry.
[4] Michal Levy,et al. nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. , 2006, Biochemical and biophysical research communications.
[5] W. Stoffel,et al. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis , 1998 .
[6] M. Wigler,et al. Cloning the differences between two complex genomes , 1993, Science.
[7] Stefan Fröhling,et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. , 2007, Cancer cell.
[8] Obeid,et al. Sphingomyelinases in cell regulation. , 1997, Seminars in cell & developmental biology.
[9] W. Lee,et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.
[10] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[11] D. Haber,et al. DOCK4, a GTPase Activator, Is Disrupted during Tumorigenesis , 2003, Cell.
[12] Y. Hannun,et al. Inhibition of Tumor Necrosis Factor-induced Cell Death in MCF7 by a Novel Inhibitor of Neutral Sphingomyelinase* , 2002, The Journal of Biological Chemistry.
[13] R. Saiki,et al. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.
[14] J. Jaffrezou,et al. Signalling sphingomyelinases: which, where, how and why? , 1999, Biochimica et biophysica acta.
[15] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[16] L. Feuk,et al. Detection of large-scale variation in the human genome , 2004, Nature Genetics.
[17] D. Housman,et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.
[18] Y. Hannun,et al. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.
[19] A. Karakashian,et al. Expression of neutral sphingomyelinase‐2 (NSMase‐2) in primary rat hepatocytes modulates IL‐β‐induced JNK activation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] L. Chin,et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.
[21] Y. Hannun. Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.
[22] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[23] W. Stoffel,et al. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] Yusuf A. Hannun,et al. Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.
[25] Jacek Bielawski,et al. Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells* , 2004, Journal of Biological Chemistry.
[26] W. Stoffel,et al. Neutral Sphingomyelinase 1 Deficiency in the Mouse Causes No Lipid Storage Disease , 2002, Molecular and Cellular Biology.
[27] Y. Hannun,et al. Role for Neutral Sphingomyelinase-2 in Tumor Necrosis Factor α-Stimulated Expression of Vascular Cell Adhesion Molecule-1 (VCAM) and Intercellular Adhesion Molecule-1 (ICAM) in Lung Epithelial Cells , 2007, Journal of Biological Chemistry.
[28] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[29] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[30] T. Lister,et al. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. , 1992, Leukemia.
[31] E. Estey,et al. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. , 1995, Leukemia.
[32] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[33] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[34] D. Haber,et al. The Wilms tumor suppressor WT1 directs stage‐specific quiescence and differentiation of human hematopoietic progenitor cells , 2001, The EMBO journal.
[35] D. Haber,et al. Cancer: Drivers and passengers , 2007, Nature.
[36] M. Bittner,et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Jacks,et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. , 1998, Genes & development.
[38] J. Testa,et al. Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] M. Krönke,et al. Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein* , 2006, Journal of Biological Chemistry.
[40] R. Desnick,et al. Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. , 1991, The Journal of biological chemistry.
[41] Giovanni Parmigiani,et al. Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers , 2003, Nature Reviews Cancer.
[42] C. Bishop,et al. A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse , 2005, Nature Genetics.
[43] W. Stoffel,et al. Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.